Malta

Every list of EU states allowing prescription mail order includes Malta. The Malta Medicines Authority’s own page, which is the national register the EMA points to, says this:

> The establishment of pharmacies is regulated by the Medicines Act, Chapter 458 of the Laws of Malta and Subsidiary Legislation 458.16. This legislation caters for the establishment of physical community pharmacies but does not provide for the establishment of internet pharmacies. In fact there are no internet pharmacies established in Malta to-date.

The register section itself, required by article 85c(4) of Directive 2001/83/EC, is empty. Reading Cap. 458 and its subsidiary legislation confirms it: there is no mention anywhere of distance selling, mail order, the internet, information society services or the EU common logo. Malta appears never to have transposed article 85c.

The likely origin of the error is a conflation. Malta permits its residents to receive medicines bought from an internet pharmacy established elsewhere in the EU, for personal use and against a valid prescription, and the Authority says so on the same page. What it does not permit is establishing one in Malta. A list built from the outbound-supply perspective, which is the one that matters to an operator, should not contain Malta.

So the corrected count of EU states permitting outbound prescription mail order is still seven, but a different seven: Malta out, Lithuania in.

Article 66(1) of Cap. 458 makes it unlawful for any person to keep a pharmacy without a licence, and nowhere requires that person to be a pharmacist. Article 67(1)(d) asks only for the name of a managing pharmacist, and article 74 obliges the licensee to employ that pharmacist and to in no way interfere with their professional judgement. The statute plainly contemplates a corporate licensee employing a pharmacist.

The only ownership disqualification is professional. Regulation 3 of S.L. 458.16 bars any medical practitioner, dental surgeon or veterinary surgeon from holding a licence, from any agreement for a share in the profits of a pharmacy, from any direct or indirect interest of whatever nature, and from lending their name so that the business is carried on by another. For a telehealth operator that is the one real trap: putting your prescribing doctors into the equity of a Maltese pharmacy is unlawful, and the anti-fronting wording is broad enough to catch nominee arrangements.

What rations entry instead is geography. Regulation 4 sets a ceiling of one pharmacy per 2,500 inhabitants, a minimum 300 metres walking distance between pharmacies, and a minimum of two per town or village. Regulation 5(1) bars a licensee from a second pharmacy in the same locality, and regulation 5(2) ranks incumbents behind first-time applicants elsewhere. Article 75(3) separately bars one pharmacist from managing two pharmacies without written authority.

Article 81(3) of Cap. 458 provides that a Maltese pharmacist may dispense on the prescription of a doctor, dentist or vet from any EU member state, provided the pharmacist can satisfy themselves that the prescriber is licensed in the state of origin. Rule 3(d) of S.L. 458.49 accepts electronically generated prescriptions including digitally signed ones, and rule 3(b) requires a cross-border prescription to carry the prescriber’s member state and international contact details.

Put together: a prescription written by a doctor registered in Germany or Ireland, delivered electronically with a digital signature, is dispensable at a Maltese counter. Prescription validity is six months, ten days for antibiotics. Telephone instructions alone are only good for 48 hours in a genuine emergency, under rule 4(3).

That makes Malta workable as a hybrid: EU-registered prescribers, digital consultation, physical Maltese dispensing. It does not make a pure digital funnel possible, because rule 4(1) of S.L. 458.49 reserves dispensing against a prescription to a pharmacist licensed in Malta. Whether that binds a foreign-established pharmacy supplying into Malta, or only conduct on Maltese soil, is unresolved and is the single most important open question here.

Malta had the highest overweight and obesity rates among both adults and adolescents in the EU in 2022. Just over one in four adults, 26%, were obese. Nearly a third of 15-year-olds, 32%, were overweight or obese, roughly 1.5 times the EU average. Only 12% of 15-year-olds reported daily moderate physical activity.

The payment structure compounds it. Free outpatient medicines run through the yellow card, tied to the Fifth Schedule Part II condition list, and the means-tested pink card. Pink card holders were 3% of the population in 2025; the two schemes together cover roughly 30%. Two thirds of Maltese already pay full price for outpatient prescriptions as a matter of routine. Out-of-pocket pharmaceutical spending was 41% in 2023 against an EU average of 39%, and retail pharmaceuticals took 18% of health spending against an EU average of 13%, the second highest share in the EU.

Obesity is absent from the Social Security Act entirely: no occurrence of obesity, obese, weight loss, weight management or bariatric anywhere in the text. So the weight-management category is pure self-pay by construction, in a population predisposed both clinically and financially. On a per-capita basis this is the best demand case in the atlas. On an absolute basis it is 550,000 people.